<!DOCTYPE html>
<html lang="en"><head><title>Glossary</title><meta charset="utf-8"/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Schibsted Grotesk:wght@400;700&amp;family=Source Sans Pro:ital,wght@0,400;0,600;1,400;1,600&amp;family=IBM Plex Mono:wght@400;600&amp;display=swap"/><link rel="preconnect" href="https://cdnjs.cloudflare.com" crossorigin="anonymous"/><meta name="viewport" content="width=device-width, initial-scale=1.0"/><meta name="og:site_name" content="Web Of Biocatalysis"/><meta property="og:title" content="Glossary"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Glossary"/><meta name="twitter:description" content="A 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) — Synthetic phenethylamine psychedelic synthesized by Alexander Shulgin; known for tactile enhancement and relatively clear headspace."/><meta property="og:description" content="A 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) — Synthetic phenethylamine psychedelic synthesized by Alexander Shulgin; known for tactile enhancement and relatively clear headspace."/><meta property="og:image:alt" content="A 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) — Synthetic phenethylamine psychedelic synthesized by Alexander Shulgin; known for tactile enhancement and relatively clear headspace."/><meta property="twitter:domain" content="glecko.xyz"/><meta property="og:url" content="https://glecko.xyz/00_INDEX/Glossary"/><meta property="twitter:url" content="https://glecko.xyz/00_INDEX/Glossary"/><link rel="icon" href="../static/icon.png"/><meta name="description" content="A 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) — Synthetic phenethylamine psychedelic synthesized by Alexander Shulgin; known for tactile enhancement and relatively clear headspace."/><meta name="generator" content="Quartz"/><link href="../index.css" rel="stylesheet" type="text/css" spa-preserve/><style>.expand-button {
  position: absolute;
  display: flex;
  float: right;
  padding: 0.4rem;
  margin: 0.3rem;
  right: 0;
  color: var(--gray);
  border-color: var(--dark);
  background-color: var(--light);
  border: 1px solid;
  border-radius: 5px;
  opacity: 0;
  transition: 0.2s;
}
.expand-button > svg {
  fill: var(--light);
  filter: contrast(0.3);
}
.expand-button:hover {
  cursor: pointer;
  border-color: var(--secondary);
}
.expand-button:focus {
  outline: 0;
}

pre:hover > .expand-button {
  opacity: 1;
  transition: 0.2s;
}

#mermaid-container {
  position: fixed;
  contain: layout;
  z-index: 999;
  left: 0;
  top: 0;
  width: 100vw;
  height: 100vh;
  overflow: hidden;
  display: none;
  backdrop-filter: blur(4px);
  background: rgba(0, 0, 0, 0.5);
}
#mermaid-container.active {
  display: inline-block;
}
#mermaid-container > #mermaid-space {
  border: 1px solid var(--lightgray);
  background-color: var(--light);
  border-radius: 5px;
  position: fixed;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  height: 80vh;
  width: 80vw;
  overflow: hidden;
}
#mermaid-container > #mermaid-space > .mermaid-content {
  padding: 2rem;
  position: relative;
  transform-origin: 0 0;
  transition: transform 0.1s ease;
  overflow: visible;
  min-height: 200px;
  min-width: 200px;
}
#mermaid-container > #mermaid-space > .mermaid-content pre {
  margin: 0;
  border: none;
}
#mermaid-container > #mermaid-space > .mermaid-content svg {
  max-width: none;
  height: auto;
}
#mermaid-container > #mermaid-space > .mermaid-controls {
  position: absolute;
  bottom: 20px;
  right: 20px;
  display: flex;
  gap: 8px;
  padding: 8px;
  background: var(--light);
  border: 1px solid var(--lightgray);
  border-radius: 6px;
  box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
  z-index: 2;
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button {
  display: flex;
  align-items: center;
  justify-content: center;
  width: 32px;
  height: 32px;
  padding: 0;
  border: 1px solid var(--lightgray);
  background: var(--light);
  color: var(--dark);
  border-radius: 4px;
  cursor: pointer;
  font-size: 16px;
  font-family: var(--bodyFont);
  transition: all 0.2s ease;
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button:hover {
  background: var(--lightgray);
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button:active {
  transform: translateY(1px);
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button:nth-child(2) {
  width: auto;
  padding: 0 12px;
  font-size: 14px;
}
/*# sourceMappingURL=data:application/json;charset=utf-8;base64,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 */</style><link href="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/katex.min.css" rel="stylesheet" type="text/css" spa-preserve/><script src="../prescript.js" type="application/javascript" spa-preserve></script><script type="application/javascript" spa-preserve>const fetchData = fetch("../static/contentIndex.json").then(data => data.json())</script><link rel="alternate" type="application/rss+xml" title="RSS Feed" href="https://glecko.xyz/index.xml"/><meta property="og:image:width" content="1200"/><meta property="og:image:height" content="630"/><meta property="og:image" content="https://glecko.xyz/00_INDEX/Glossary-og-image.webp"/><meta property="og:image:url" content="https://glecko.xyz/00_INDEX/Glossary-og-image.webp"/><meta name="twitter:image" content="https://glecko.xyz/00_INDEX/Glossary-og-image.webp"/><meta property="og:image:type" content="image/.webp"/></head><body data-slug="00_INDEX/Glossary"><div id="quartz-root" class="page"><div id="quartz-body"><div class="left sidebar"><h2 class="page-title"><a href="..">Web Of Biocatalysis</a></h2><div class="spacer mobile-only"></div><div style="display: flex; flex-direction: row; flex-wrap: nowrap; gap: 1rem;"><div style="flex-grow: 1; flex-shrink: 1; flex-basis: auto; order: 0; align-self: center; justify-self: center;"><div class="search"><button class="search-button"><p>Search</p><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title>Search</title><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"></path><circle cx="8" cy="8" r="7"></circle></g></svg></button><div class="search-container"><div class="search-space"><input autocomplete="off" class="search-bar" name="search" type="text" aria-label="Search for something" placeholder="Search for something"/><div class="search-layout" data-preview="true"></div></div></div></div></div><div style="flex-grow: 0; flex-shrink: 1; flex-basis: auto; order: 0; align-self: center; justify-self: center;"><button class="darkmode"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="dayIcon" x="0px" y="0px" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35" xml:space="preserve" aria-label="Dark mode"><title>Dark mode</title><path d="M6,17.5C6,16.672,5.328,16,4.5,16h-3C0.672,16,0,16.672,0,17.5    S0.672,19,1.5,19h3C5.328,19,6,18.328,6,17.5z M7.5,26c-0.414,0-0.789,0.168-1.061,0.439l-2,2C4.168,28.711,4,29.086,4,29.5    C4,30.328,4.671,31,5.5,31c0.414,0,0.789-0.168,1.06-0.44l2-2C8.832,28.289,9,27.914,9,27.5C9,26.672,8.329,26,7.5,26z M17.5,6    C18.329,6,19,5.328,19,4.5v-3C19,0.672,18.329,0,17.5,0S16,0.672,16,1.5v3C16,5.328,16.671,6,17.5,6z M27.5,9    c0.414,0,0.789-0.168,1.06-0.439l2-2C30.832,6.289,31,5.914,31,5.5C31,4.672,30.329,4,29.5,4c-0.414,0-0.789,0.168-1.061,0.44    l-2,2C26.168,6.711,26,7.086,26,7.5C26,8.328,26.671,9,27.5,9z M6.439,8.561C6.711,8.832,7.086,9,7.5,9C8.328,9,9,8.328,9,7.5    c0-0.414-0.168-0.789-0.439-1.061l-2-2C6.289,4.168,5.914,4,5.5,4C4.672,4,4,4.672,4,5.5c0,0.414,0.168,0.789,0.439,1.06    L6.439,8.561z M33.5,16h-3c-0.828,0-1.5,0.672-1.5,1.5s0.672,1.5,1.5,1.5h3c0.828,0,1.5-0.672,1.5-1.5S34.328,16,33.5,16z     M28.561,26.439C28.289,26.168,27.914,26,27.5,26c-0.828,0-1.5,0.672-1.5,1.5c0,0.414,0.168,0.789,0.439,1.06l2,2    C28.711,30.832,29.086,31,29.5,31c0.828,0,1.5-0.672,1.5-1.5c0-0.414-0.168-0.789-0.439-1.061L28.561,26.439z M17.5,29    c-0.829,0-1.5,0.672-1.5,1.5v3c0,0.828,0.671,1.5,1.5,1.5s1.5-0.672,1.5-1.5v-3C19,29.672,18.329,29,17.5,29z M17.5,7    C11.71,7,7,11.71,7,17.5S11.71,28,17.5,28S28,23.29,28,17.5S23.29,7,17.5,7z M17.5,25c-4.136,0-7.5-3.364-7.5-7.5    c0-4.136,3.364-7.5,7.5-7.5c4.136,0,7.5,3.364,7.5,7.5C25,21.636,21.636,25,17.5,25z"></path></svg><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="nightIcon" x="0px" y="0px" viewBox="0 0 100 100" style="enable-background:new 0 0 100 100" xml:space="preserve" aria-label="Light mode"><title>Light mode</title><path d="M96.76,66.458c-0.853-0.852-2.15-1.064-3.23-0.534c-6.063,2.991-12.858,4.571-19.655,4.571  C62.022,70.495,50.88,65.88,42.5,57.5C29.043,44.043,25.658,23.536,34.076,6.47c0.532-1.08,0.318-2.379-0.534-3.23  c-0.851-0.852-2.15-1.064-3.23-0.534c-4.918,2.427-9.375,5.619-13.246,9.491c-9.447,9.447-14.65,22.008-14.65,35.369  c0,13.36,5.203,25.921,14.65,35.368s22.008,14.65,35.368,14.65c13.361,0,25.921-5.203,35.369-14.65  c3.872-3.871,7.064-8.328,9.491-13.246C97.826,68.608,97.611,67.309,96.76,66.458z"></path></svg></button></div></div><div class="explorer" data-behavior="link" data-collapsed="collapsed" data-savestate="true" data-data-fns="{&quot;order&quot;:[&quot;filter&quot;,&quot;map&quot;,&quot;sort&quot;],&quot;sortFn&quot;:&quot;(a,b)=>!a.isFolder&amp;&amp;!b.isFolder||a.isFolder&amp;&amp;b.isFolder?a.displayName.localeCompare(b.displayName,void 0,{numeric:!0,sensitivity:\&quot;base\&quot;}):!a.isFolder&amp;&amp;b.isFolder?1:-1&quot;,&quot;filterFn&quot;:&quot;node=>node.slugSegment!==\&quot;tags\&quot;&quot;,&quot;mapFn&quot;:&quot;node=>node&quot;}"><button type="button" class="explorer-toggle mobile-explorer hide-until-loaded" data-mobile="true" aria-controls="explorer-content"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide-menu"><line x1="4" x2="20" y1="12" y2="12"></line><line x1="4" x2="20" y1="6" y2="6"></line><line x1="4" x2="20" y1="18" y2="18"></line></svg></button><button type="button" class="title-button explorer-toggle desktop-explorer" data-mobile="false" aria-expanded="true"><h2>Explorer</h2><svg xmlns="http://www.w3.org/2000/svg" width="14" height="14" viewBox="5 8 14 8" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="fold"><polyline points="6 9 12 15 18 9"></polyline></svg></button><div class="explorer-content" aria-expanded="false"><ul class="explorer-ul overflow" id="c8nqq2"><li class="overflow-end"></li></ul></div><template id="template-file"><li><a href="#"></a></li></template><template id="template-folder"><li><div class="folder-container"><svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" viewBox="5 8 14 8" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="folder-icon"><polyline points="6 9 12 15 18 9"></polyline></svg><div><button class="folder-button"><span class="folder-title"></span></button></div></div><div class="folder-outer"><ul class="content"></ul></div></li></template></div></div><div class="center"><div class="page-header"><div class="popover-hint"><nav class="breadcrumb-container" aria-label="breadcrumbs"><div class="breadcrumb-element"><a href="../">Home</a><p> ❯ </p></div><div class="breadcrumb-element"><a href="../00_INDEX/">00_INDEX</a><p> ❯ </p></div><div class="breadcrumb-element"><a href>Glossary</a></div></nav></div></div><article class="popover-hint"><h2 id="a">A<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#a" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>2C-B (4-Bromo-2,5-dimethoxyphenethylamine)</strong> — Synthetic phenethylamine psychedelic synthesized by Alexander Shulgin; known for tactile enhancement and relatively clear headspace. <a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>2C-I, 2C-E, 2C-T-2, 2C-T-7</strong> — Series of synthetic phenethylamine psychedelics from Shulgin’s research; varying in potency and character. <a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>4-AcO-DMT (Psilacetin)</strong> — Synthetic tryptamine structurally similar to psilocybin; likely metabolizes to psilocin in the body.</p>
<p><strong>4-HO-MET (Metocin)</strong> — Synthetic tryptamine analog of psilocin with lighter mental effects and pronounced visuals. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>5-HT receptor family</strong> — Serotonin receptor subtypes (5-HT1A through 5-HT7) with varying roles in psychedelic pharmacology.</p>
<p><strong>5-HT2A receptor</strong> — Primary serotonin receptor subtype responsible for classical psychedelic effects; G-protein coupled receptor.</p>
<p><strong>5-HT2B receptor</strong> — Serotonin receptor implicated in cardiac valvulopathy with chronic activation; safety concern for some psychedelics.</p>
<p><strong>5-HT2C receptor</strong> — Serotonin receptor contributing to anxiety, appetite, and some psychedelic effects.</p>
<p><strong>5-MeO-DALT</strong> — Synthetic tryptamine with unique pharmacology; less visual than other tryptamines. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>5-MeO-DiPT (Foxy)</strong> — Synthetic tryptamine known for auditory distortions and tactile enhancement. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong><a href="../01_SUBSTANCES/CLASSICS/5-MeO-DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/5-MeO-DMT">5-MeO-DMT</a></strong> — Potent naturally occurring tryptamine; found in Bufo alvarius/Incilius alvarius toad secretions and various plants; primarily non-visual.</p>
<p><strong>5-MeO-MiPT (Moxy)</strong> — Synthetic tryptamine with empathogenic qualities alongside psychedelic effects. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>Absorption</strong> — Process by which a substance enters systemic circulation; varies by route of administration.</p>
<p><strong>Acacia species</strong> — Australian trees containing DMT and other tryptamines in bark and leaves; used in “Aussie-huasca.”</p>
<p><strong>Active dose</strong> — Minimum amount of a substance required to produce noticeable psychoactive effects.</p>
<p><strong>Acute tolerance</strong> — Immediate reduction in drug effects during a single session or with repeated dosing.</p>
<p><strong>Addiction potential</strong> — Likelihood of developing dependence; generally low for classical psychedelics.</p>
<p><strong>Afterglow</strong> — Positive mood and cognitive effects persisting days to weeks after a psychedelic experience.</p>
<p><strong>Agonist</strong> — Molecule that activates a receptor; psychedelics are primarily 5-HT2A agonists or partial agonists.</p>
<p><strong>AL-LAD</strong> — Lysergamide analog of LSD with shorter duration and more visual character.
<a href="../01_SUBSTANCES/Synthetic-Classes/LSD-analogues" class="internal alias" data-slug="01_SUBSTANCES/Synthetic-Classes/LSD-analogues">LSD analogues</a></p>
<p><strong><a href="../02_PEOPLE/The-Cultural-Catalysts/Aldous-Huxley" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Aldous-Huxley">Aldous Huxley</a></strong> — British author of “The Doors of Perception” (1954) and “Heaven and Hell” (1956); coined term “psychedelic.”</p>
<p><strong>Alexander “Sasha” Shulgin</strong> — American chemist who synthesized and tested hundreds of psychedelics; author of <a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a> and <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a>. <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>Allosteric modulation</strong> — Indirect receptor regulation by binding at sites other than the primary binding site.</p>
<p><strong><a href="../01_SUBSTANCES/Ethnobotanical/Amanita-muscaria" class="internal alias" data-slug="01_SUBSTANCES/Ethnobotanical/Amanita-muscaria">Amanita muscaria</a></strong> — Psychoactive mushroom containing muscimol and ibotenic acid; distinct from psilocybin mushrooms.</p>
<p><strong>Amanda Feilding</strong> — British drug policy reformer and founder of the Beckley Foundation.</p>
<p><strong>AMT (α-Methyltryptamine)</strong> — Long-acting synthetic tryptamine with stimulant and psychedelic properties. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></p>
<p><strong>Anadenanthera colubrina/peregrina</strong> — South American trees whose seeds contain <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a>, <a href="../01_SUBSTANCES/CLASSICS/5-MeO-DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/5-MeO-DMT">5-MeO-DMT</a>, and bufotenine.</p>
<p><strong>Analog (drug)</strong> — Chemical compound structurally similar to another; basis for the Federal Analog Act.</p>
<p><strong>Anandamide</strong> — Endogenous cannabinoid neurotransmitter; name means “bliss molecule” in Sanskrit.</p>
<p><strong>Ann Shulgin</strong> — Co-author with <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a>; pioneered lay therapy with MDMA and psychedelics.</p>
<p><strong>Antagonist</strong> — Molecule that blocks receptor activation by other compounds.</p>
<p><strong>Anxiolytic</strong> — Substance or effect that reduces anxiety.</p>
<p><strong>Apoptosis</strong> — Programmed cell death; some psychedelics show anti-apoptotic properties.</p>
<p><strong>Argyreia nervosa (Hawaiian Baby Woodrose)</strong> — Seeds containing LSA and other ergot alkaloids.</p>
<p><strong><a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a></strong> — Traditional Amazonian brew combining <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a>-containing plants with MAO-inhibiting B. caapi vine.</p>
<p><strong>Ayahuasca churches</strong> — Religious organizations using ayahuasca sacramentally (Santo Daime, UDV, Barquinha).</p>
<h2 id="b">B<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#b" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Bad trip</strong> — Difficult or challenging psychedelic experience characterized by anxiety, fear, or distressing content. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Banisteriopsis caapi</strong> — “Vine of the soul”; contains β-carboline MAO inhibitors enabling oral DMT activity. <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a></p>
<p><strong>Baseline</strong> — Normal psychological state before substance administration.</p>
<p><strong>BDNF (Brain-Derived Neurotrophic Factor)</strong> — Protein promoting neuroplasticity; increased by some psychedelics.</p>
<p><strong>Beckley Foundation</strong> — UK-based think tank researching psychedelics and drug policy reform.</p>
<p><strong>Behavioral tolerance</strong> — Learned compensation for drug effects through practice.</p>
<p><strong>Bioavailability</strong> — Proportion of administered drug reaching systemic circulation.</p>
<p><strong>Biogenetic structuralism</strong> — Theory linking neurobiology to religious/mystical experiences.</p>
<p><strong>Blood-brain barrier</strong> — Selective membrane preventing most substances from entering the brain.</p>
<p><strong>Breakthrough dose</strong> — Amount of DMT (typically 25-50mg vaporized) producing complete immersion in visionary space. <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a></p>
<p><strong>Breathwork</strong> — Non-pharmacological technique producing altered states; often used in integration.</p>
<p><strong>Bufo alvarius (Incilius alvarius)</strong> — Sonoran Desert toad producing 5-MeO-DMT and bufotenine in skin secretions. <a href="../01_SUBSTANCES/CLASSICS/5-MeO-DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/5-MeO-DMT">5-MeO-DMT</a></p>
<p><strong>Bufotenine (5-HO-DMT)</strong> — Tryptamine found in toads and plants; disputed psychoactivity when pure.</p>
<h2 id="c">C<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#c" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Candyflipping</strong> — Combining LSD and MDMA for synergistic effects.</p>
<p><strong>Cannabis</strong> — Plant containing THC and CBD; often combined with psychedelics despite interaction risks.</p>
<p><strong>Carhart-Harris, Robin</strong> — British neuroscientist; developed REBUS model and entropic brain hypothesis.</p>
<p><strong>Catalytic dose</strong> — Sub-perceptual amount of a substance used to facilitate therapy or meditation. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Changa</strong> — Smokeable blend of <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a>-enhanced herbs with MAO inhibitors for extended duration.</p>
<p><strong>Charles Grob</strong> — American psychiatrist conducting psilocybin studies for anxiety in cancer patients.</p>
<p><strong>Chemical imbalance theory</strong> — Disputed model of mental illness; challenged by psychedelic research. <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a></p>
<p><strong>Chromatography</strong> — Laboratory technique for separating and identifying compounds.</p>
<p><strong>Claudio Naranjo</strong> — Chilean psychiatrist pioneering psychedelic therapy with ibogaine and MDA.</p>
<p><strong>Closed-eye visuals (CEVs)</strong> — Visual phenomena experienced with eyes closed during psychedelic states.</p>
<p><strong>Cognitive flexibility</strong> — Mental ability to adapt thinking; enhanced by psychedelics.</p>
<p><strong>Collective unconscious</strong> — Jungian concept often referenced in psychedelic discourse.</p>
<p><strong>Come-up</strong> — Initial phase of drug effects manifesting; often accompanied by anxiety.</p>
<p><strong>Consciousness</strong> — Subjective awareness; central mystery in psychedelic research.</p>
<p><strong>Controlled Substances Act</strong> — 1970 U.S. law placing most psychedelics in Schedule I. <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a> <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> <a href="../02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary">Timothy Leary</a></p>
<p><strong>Cross-tolerance</strong> — Reduced response to one drug due to tolerance from another.</p>
<p><strong>Cytochrome P450</strong> — Liver enzyme family metabolizing many drugs including psychedelics.</p>
<h2 id="d">D<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#d" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>David Nichols</strong> — American pharmacologist; founded Heffter Research Institute; coined “entactogen.”</p>
<p><strong>David Nutt</strong> — British neuropsychopharmacologist advocating evidence-based drug policy.</p>
<p><strong>Decriminalization</strong> — Removing criminal penalties for personal possession/use.</p>
<p><strong>Default Mode Network (DMN)</strong> — Brain network associated with self-referential processing; disrupted by psychedelics.</p>
<p><strong><a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Dennis-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Dennis-McKenna">Dennis McKenna</a></strong> — Ethnopharmacologist and brother of <a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna">Terence McKenna</a>; expert on ayahuasca and plant hallucinogens.</p>
<p><strong>Depersonalization</strong> — Loss of sense of personal identity; related to ego dissolution.</p>
<p><strong>Derealization</strong> — Feeling that external world is unreal; can occur with high doses.</p>
<p><strong>DET (Diethyltryptamine)</strong> — Synthetic tryptamine similar to DMT but orally active. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></p>
<p><strong>Dimethyltryptamine (<a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a>)</strong> — “The spirit molecule”; endogenous psychedelic tryptamine.</p>
<p><strong>DiPT (Diisopropyltryptamine)</strong> — Unique tryptamine primarily causing auditory distortions. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></p>
<p><strong>Dissociation</strong> — Detachment from physical/emotional experience; primary effect of <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine">Ketamine</a>, PCP.</p>
<p><strong>Distribution (pharmacokinetics)</strong> — Movement of drug throughout body tissues.</p>
<p><strong>DOM (STP)</strong> — Long-acting psychedelic amphetamine; caused overdoses in 1960s San Francisco.</p>
<p><strong>Dopamine</strong> — Neurotransmitter involved in reward, motivation; indirectly affected by psychedelics.</p>
<p><strong>Dose-response curve</strong> — Graph showing relationship between drug amount and effect magnitude.</p>
<p><strong>Double-blind</strong> — Research design where neither participants nor researchers know who receives drug vs placebo.</p>
<p><strong>DPT (Dipropyltryptamine)</strong> — Synthetic tryptamine used by Temple of the True Inner Light. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></p>
<p><strong>Drug scheduling</strong> — Legal classification system for controlled substances.</p>
<h2 id="e">E<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#e" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Ecstasy</strong> — Street name for <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA">MDMA</a>; often adulterated with other substances.</p>
<p><strong>Effective dose (ED50)</strong> — Amount producing desired effect in 50% of population.</p>
<p><strong>Ego death/dissolution</strong> — Complete loss of subjective self-identity.</p>
<p><strong>Elimination half-life</strong> — Time for drug concentration to decrease by 50%.</p>
<p><strong>Empathogen/Entactogen</strong> — Substances increasing emotional openness (<a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA">MDMA</a>, <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDA">MDA</a>).</p>
<p><strong>Endogenous</strong> — Naturally produced within the body.</p>
<p><strong>Entheogen</strong> — “Generating the divine within”; spiritual context for psychedelics. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Entity contact</strong> — Encounters with seemingly autonomous beings during psychedelic experiences.</p>
<p><strong>Entropic brain hypothesis</strong> — Theory that psychedelics increase neural entropy/complexity.</p>
<p><strong>Enzyme</strong> — Protein catalyzing biochemical reactions; crucial for drug metabolism.</p>
<p><strong>Epigenetics</strong> — Gene expression changes without DNA sequence alteration; potentially affected by psychedelics.</p>
<p><strong>Ergot alkaloids</strong> — Fungal compounds; precursors to LSD; found in morning glory seeds.</p>
<p><strong>ETH-LAD</strong> — Lysergamide with unique visual character; more potent than LSD by weight. <a href="../01_SUBSTANCES/Synthetic-Classes/LSD-analogues" class="internal alias" data-slug="01_SUBSTANCES/Synthetic-Classes/LSD-analogues">LSD analogues</a></p>
<p><strong>Ethnobotany</strong> — Study of traditional plant use by indigenous cultures. <a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Dennis-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Dennis-McKenna">Dennis McKenna</a></p>
<p><strong>Euphoria</strong> — Intense pleasure and well-being; common with MDMA, some psychedelics.</p>
<h2 id="f">F<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#f" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>First-pass metabolism</strong> — Drug breakdown in liver before reaching systemic circulation. <a href="../01_SUBSTANCES/Synthetic-Classes/LSD-analogues" class="internal alias" data-slug="01_SUBSTANCES/Synthetic-Classes/LSD-analogues">LSD analogues</a></p>
<p><strong>Flashback</strong> — Brief recurrence of psychedelic effects without recent use.</p>
<p><strong>Flow state</strong> — Optimal experience characterized by complete absorption; sometimes induced by psychedelics.</p>
<p><strong>Foxy (5-MeO-DiPT)</strong> — Synthetic tryptamine with unique auditory effects. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></p>
<p><strong>Frances Vaughan</strong> — Transpersonal psychologist; early psychedelic therapy researcher.</p>
<p><strong>Functional selectivity</strong> — Ability of drugs to selectively activate specific receptor signaling pathways.</p>
<h2 id="g">G<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#g" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>GABA</strong> — Primary inhibitory neurotransmitter; modulated by some psychedelics.</p>
<p><strong>Gillin, J. Christian</strong> — Lead author of the 1976 NIH review “<a href="../04_REFERENCES/Paper/The-Psychedelic-Model-of-Schizophrenia-(1976)" class="internal alias" data-slug="04_REFERENCES/Paper/The-Psychedelic-Model-of-Schizophrenia-(1976)">The Psychedelic Model of Schizophrenia (1976)</a>.”</p>
<p><strong>Glutamate</strong> — Primary excitatory neurotransmitter; NMDA antagonists produce dissociation.</p>
<p><strong>Gordon Wasson</strong> — Banker/mycologist who publicized psilocybin mushrooms in Life magazine (1957).</p>
<p><strong>Grof, Stanislav</strong> — Czech psychiatrist developing psychedelic therapy and holotropic breathwork.</p>
<h2 id="h">H<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#h" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Half-life</strong> — Time for drug concentration to reduce by 50%.</p>
<p><strong>Hallucinogen</strong> — Outdated term for psychedelics; implies false perceptions. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Hallucinogen Persisting Perception Disorder (HPPD)</strong> — Persistent visual disturbances following psychedelic use.</p>
<p><strong><a href="../02_PEOPLE/The-Cultural-Catalysts/Hamilton-Morris" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Hamilton-Morris">Hamilton Morris</a></strong> — Journalist/chemist documenting psychoactive substances in “Hamilton’s Pharmacopeia.”</p>
<p><strong>Harmala alkaloids</strong> — β-carbolines (harmine, harmaline, THH) inhibiting MAO.</p>
<p><strong>Harm reduction</strong> — Pragmatic approach minimizing drug-related harm without requiring abstinence.</p>
<p><strong>Head space</strong> — Cognitive/emotional aspects of psychedelic experience. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a> <a href="../03_CONCEPTS/Set,-Setting-and-the-Substance" class="internal alias" data-slug="03_CONCEPTS/Set,-Setting-and-the-Substance">Set, Setting and the Substance</a></p>
<p><strong>Heffter Research Institute</strong> — Organization funding psychedelic research since 1993.</p>
<p><strong>Heroic dose</strong> — <a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna">Terence McKenna</a>’s term for 5+ grams dried psilocybin mushrooms.</p>
<p><strong>Hippie flip</strong> — Combining <a href="../01_SUBSTANCES/CLASSICS/Psilocybin" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Psilocybin">Psilocybin</a> mushrooms with <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA">MDMA</a>.</p>
<p><strong><a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Albert-Hofmann" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Albert-Hofmann">Albert Hofmann</a></strong> — Swiss chemist who discovered <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> (1938) and isolated <a href="../01_SUBSTANCES/CLASSICS/Psilocybin" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Psilocybin">Psilocybin</a> (1958).</p>
<p><strong>Holotropic breathwork</strong> — Stanislav Grof’s technique inducing non-ordinary states without drugs.</p>
<p><strong>Humphry Osmond</strong> — British psychiatrist who coined “psychedelic” in correspondence with <a href="../02_PEOPLE/The-Cultural-Catalysts/Aldous-Huxley" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Aldous-Huxley">Aldous Huxley</a>.</p>
<p><strong>Hyperspace</strong> — <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a> users’ term for visionary realm accessed during breakthrough experiences.</p>
<h2 id="i">I<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#i" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Iboga</strong> — West African shrub containing ibogaine; used in Bwiti tradition. <a href="../01_SUBSTANCES/Ethnobotanical/Ibogain" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ibogain">Ibogain</a></p>
<p><strong><a href="../Ibogaine" class="internal" data-slug="Ibogaine">Ibogaine</a></strong> — Indole alkaloid with anti-addictive properties; produces waking dream state.</p>
<p><strong>Imperial College London</strong> — Leading institution for psychedelic neuroimaging research.</p>
<p><strong>INMT (Indolethylamine N-Methyltransferase)</strong> — Enzyme methylating tryptamine to form <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a>.</p>
<p><strong>Integration</strong> — Processing and incorporating psychedelic experiences into daily life. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Intention setting</strong> — Establishing purpose before psychedelic experience. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Intramuscular (IM)</strong> — Injection into muscle tissue; used in some research.</p>
<p><strong>Intravenous (IV)</strong> — Direct injection into vein; produces rapid onset.</p>
<p><strong>Ipomoea tricolor</strong> — Morning glory species containing LSA. <a href="../01_SUBSTANCES/Synthetic-Classes/LSD-analogues" class="internal alias" data-slug="01_SUBSTANCES/Synthetic-Classes/LSD-analogues">LSD analogues</a></p>
<h2 id="j">J<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#j" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>James Fadiman</strong> — Psychologist researching psychedelics since 1960s; popularized microdosing.</p>
<p><strong>Jedi flip</strong> — Combining <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a>, <a href="../01_SUBSTANCES/CLASSICS/Psilocybin" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Psilocybin">Psilocybin</a>, and <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA">MDMA</a>.</p>
<p><strong>Johns Hopkins</strong> — University conducting landmark psilocybin research since 2000s.</p>
<p><strong>Jung, Carl</strong> — Psychologist whose concepts (shadow, individuation) inform psychedelic therapy.</p>
<h2 id="k">K<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#k" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>K-hole</strong> — Deep dissociative state from high-dose <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine">Ketamine</a>.</p>
<p><strong>Kappa opioid receptor</strong> — Target of Salvinorin A producing unique dissociative effects.</p>
<p><strong>Katherine MacLean</strong> — Psychologist researching personality changes from psilocybin.</p>
<p><strong>Ken Kesey</strong> — Author who popularized <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> through “Acid Tests” with Merry Pranksters.</p>
<p><strong><a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine">Ketamine</a></strong> — Dissociative anesthetic with rapid antidepressant effects; NMDA antagonist.</p>
<p><strong>Kitty flipping</strong> — Combining <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine">Ketamine</a> with <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA">MDMA</a>.</p>
<h2 id="l">L<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#l" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Language distortion</strong> — Difficulty forming coherent speech at high doses.</p>
<p><strong>Laura Huxley</strong> — <a href="../02_PEOPLE/The-Cultural-Catalysts/Aldous-Huxley" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Aldous-Huxley">Aldous Huxley</a>’s wife; administered <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> on his deathbed.</p>
<p><strong>LD50 (Lethal Dose 50%)</strong> — Amount causing death in 50% of test subjects.</p>
<p><strong><a href="../02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary">Timothy Leary</a></strong> — Harvard psychologist turned <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> evangelist; “Turn on, tune in, drop out.”</p>
<p><strong>Leo Zeff</strong> — “Secret Chief”; underground psychedelic therapist training many practitioners.</p>
<p><strong>Lilly, John C.</strong> — Neuroscientist exploring consciousness with isolation tanks and <a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/Ketamine">Ketamine</a>.</p>
<p><strong>Lophophora williamsii</strong> — <a href="../01_SUBSTANCES/Ethnobotanical/Peyote-Cactus" class="internal alias" data-slug="01_SUBSTANCES/Ethnobotanical/Peyote-Cactus">Peyote Cactus</a> containing <a href="../01_SUBSTANCES/CLASSICS/Mescaline" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Mescaline">Mescaline</a>; used ceremonially by Native Americans.</p>
<p><strong>LSA (Lysergic Acid Amide)</strong> — Natural ergot alkaloid in morning glory and Hawaiian baby woodrose seeds.</p>
<p><strong><a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> (Lysergic Acid Diethylamide)</strong> — Semi-synthetic ergot derivative; most potent common psychedelic.</p>
<p><strong>LSZ</strong> — Lysergamide analog with unique properties; Shulgin called it “Diazedine.” <a href="../01_SUBSTANCES/Synthetic-Classes/LSD-analogues" class="internal alias" data-slug="01_SUBSTANCES/Synthetic-Classes/LSD-analogues">LSD analogues</a> <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<h2 id="m">M<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#m" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Machine elves</strong> — <a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna">Terence McKenna</a>’s term for entities encountered on <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a>.</p>
<p><strong>MAO (Monoamine Oxidase)</strong> — Enzyme breaking down monoamines; inhibited to allow oral <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a> activity. <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a></p>
<p><strong>MAOI</strong> — Monoamine oxidase inhibitor; pharmaceutical or natural (harmala alkaloids). <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a></p>
<p><strong>MAPS (Multidisciplinary Association for Psychedelic Studies)</strong> — Organization founded by <a href="../02_PEOPLE/The-Advocates--and--Institution-Builders/Rick-Doblin" class="internal alias" data-slug="02_PEOPLE/The-Advocates--and--Institution-Builders/Rick-Doblin">Rick Doblin</a> advancing psychedelic research.</p>
<p><strong><a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/María-Sabina" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/María-Sabina">María Sabina</a></strong> — Mazatec curandera who introduced psilocybin mushrooms to Westerners.</p>
<p><strong>Matthew Johnson</strong> — Johns Hopkins researcher studying psilocybin for addiction.</p>
<p><strong><a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDA">MDA</a></strong> — “Sass”; empathogenic amphetamine; parent compound of MDMA.</p>
<p><strong><a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/MDMA">MDMA</a></strong> — 3,4-Methylenedioxymethamphetamine; empathogen used in PTSD therapy.</p>
<p><strong><a href="../01_SUBSTANCES/CLASSICS/Mescaline" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Mescaline">Mescaline</a></strong> — Phenethylamine psychedelic from <a href="../01_SUBSTANCES/Ethnobotanical/Peyote-Cactus" class="internal alias" data-slug="01_SUBSTANCES/Ethnobotanical/Peyote-Cactus">Peyote Cactus</a> and San Pedro cacti.</p>
<p><strong>Metabolism</strong> — Biochemical modification of substances in the body.</p>
<p><strong><a href="../03_CONCEPTS/Microdosing" class="internal" data-slug="03_CONCEPTS/Microdosing">Microdosing</a></strong> — Taking sub-perceptual doses (typically 5-20% of active dose) for subtle benefits.</p>
<p><strong>Mimosa hostilis/tenuiflora</strong> — Root bark containing ~1% DMT; used in jurema and extraction. <a href="../04_REFERENCES/Article_Blog_Web/The-DMT-Nexus" class="internal alias" data-slug="04_REFERENCES/Article_Blog_Web/The-DMT-Nexus">The DMT Nexus</a></p>
<p><strong>Mind manifesting</strong> — Literal meaning of “psychedelic” from Greek psyche (mind) and delos (manifest). <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>MK-ULTRA</strong> — CIA program experimenting with LSD for mind control (1950s-1970s).</p>
<p><strong>Mystical experience</strong> — Profound spiritual state; measured by MEQ-30 questionnaire in research. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<h2 id="n">N<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#n" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Native American Church</strong> — Religious organization with legal peyote use. <a href="../01_SUBSTANCES/Ethnobotanical/Peyote-Cactus" class="internal alias" data-slug="01_SUBSTANCES/Ethnobotanical/Peyote-Cactus">Peyote Cactus</a></p>
<p><strong>NBOMe series</strong> — Potent phenethylamine psychedelics; associated with fatalities.</p>
<p><strong>Neurogenesis</strong> — Formation of new neurons; potentially stimulated by psychedelics. <a href="../Science--and--Research" class="internal alias" data-slug="Science--and--Research">Science &amp; Research</a></p>
<p><strong>Neuroplasticity</strong> — Brain’s ability to reorganize; enhanced by psychedelics. <a href="../Science--and--Research" class="internal alias" data-slug="Science--and--Research">Science &amp; Research</a></p>
<p><strong>Neurotransmitter</strong> — Chemical messenger between neurons.</p>
<p><strong>Nexus, The DMT</strong> — Online forum dedicated to DMT chemistry, harm reduction, and experience reports. <a href="../04_REFERENCES/Article_Blog_Web/The-DMT-Nexus" class="internal alias" data-slug="04_REFERENCES/Article_Blog_Web/The-DMT-Nexus">The DMT Nexus</a></p>
<p><strong>Nexus flip</strong> — Combining 2C-B with MDMA. <a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a></p>
<p><strong>Nicholas Sand</strong> — Underground chemist who synthesized massive quantities of LSD.</p>
<p><strong>Nitrous oxide</strong> — Dissociative gas producing brief altered state; often combined with psychedelics.</p>
<p><strong>NMDA receptor</strong> — Glutamate receptor blocked by dissociatives.</p>
<h2 id="o">O<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#o" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Oceanic boundlessness</strong> — Feeling of unity with universe; measured by 5D-ASC scale.</p>
<p><strong>Oliver Sacks</strong> — Neurologist who wrote about his psychedelic experiences.</p>
<p><strong>Open-eye visuals (OEVs)</strong> — Visual distortions with eyes open.</p>
<p><strong>Openness</strong> — Personality trait increased by psilocybin in Johns Hopkins study.</p>
<p><strong>Orange Sunshine</strong> — Famous <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> variety from 1960s-70s.</p>
<p><strong>Owsley Stanley</strong> — “Bear”; legendary LSD chemist supplying 1960s counterculture.</p>
<h2 id="p">P<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#p" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>P450 enzymes</strong> — Cytochrome P450 family metabolizing many drugs.</p>
<p><strong>Pahnke, Walter</strong> — Conducted Good Friday Experiment with psilocybin at Harvard. <a href="../01_SUBSTANCES/CLASSICS/LSD" class="internal" data-slug="01_SUBSTANCES/CLASSICS/LSD">LSD</a> <a href="../02_PEOPLE/The-Cultural-Catalysts/Ram-Dass" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Ram-Dass">Ram Dass</a></p>
<p><strong>Partial agonist</strong> — Compound producing submaximal receptor activation.</p>
<p><strong>Paul Stamets</strong> — Mycologist advocating fungal solutions and psilocybin benefits.</p>
<p><strong><a href="../01_SUBSTANCES/Empathogens--and--Dissociatives/PCP" class="internal" data-slug="01_SUBSTANCES/Empathogens--and--Dissociatives/PCP">PCP</a> (Phencyclidine)</strong> — Dissociative anesthetic; NMDA antagonist with stimulant properties.</p>
<p><strong>Peak experience</strong> — Abraham Maslow’s term for transcendent states.</p>
<p><strong>Peganum harmala (Syrian rue)</strong> — Plant containing harmala alkaloids; <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a> analog.</p>
<p><strong>Peter Gasser</strong> — Swiss psychiatrist conducting LSD-assisted psychotherapy trials.</p>
<p><strong>Peyote</strong> — Mescaline-containing cactus sacred to Native Americans. <a href="../01_SUBSTANCES/Ethnobotanical/Peyote-Cactus" class="internal alias" data-slug="01_SUBSTANCES/Ethnobotanical/Peyote-Cactus">Peyote Cactus</a></p>
<p><strong>Pharmacodynamics</strong> — Drug effects on the body via receptor interactions.</p>
<p><strong>Pharmacokinetics</strong> — Drug absorption, distribution, metabolism, excretion (ADME).</p>
<p><strong>Pharmahuasca</strong> — Ayahuasca analog using pure/synthetic compounds. <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a> <a href="../Other-Compounds" class="internal alias" data-slug="Other-Compounds">Other Compounds</a></p>
<p><strong>Phenethylamine</strong> — Chemical class including mescaline, MDMA, 2C series. <a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a></p>
<p><strong><a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a></strong> — “Phenethylamines I Have Known And Loved”; Shulgin’s phenethylamine compendium. <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a></p>
<p><strong>Pineal gland</strong> — Brain structure mystically linked to consciousness; produces melatonin, possibly DMT.</p>
<p><strong>Placebo</strong> — Inactive substance used as control in research. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Prodrug</strong> — Inactive compound metabolized into active form (e.g., psilocybin→psilocin).</p>
<p><strong>Psilocin</strong> — Active metabolite of <a href="../01_SUBSTANCES/CLASSICS/Psilocybin" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Psilocybin">Psilocybin</a>; 4-HO-DMT. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></p>
<p><strong>Psilocybe</strong> — Genus containing ~200 psilocybin mushroom species.</p>
<p><strong><a href="../01_SUBSTANCES/CLASSICS/Psilocybin" class="internal" data-slug="01_SUBSTANCES/CLASSICS/Psilocybin">Psilocybin</a></strong> — Prodrug in magic mushrooms; converted to psilocin.</p>
<p><strong>Psychedelic</strong> — “Mind-manifesting”; substances producing altered states via 5-HT2A agonism. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Psychedelic renaissance</strong> — Revival of psychedelic research since ~2000.</p>
<p><strong>Psychedelic therapy</strong> — Using psychedelics as adjuncts to psychotherapy.</p>
<p><strong>Psycholytic therapy</strong> — Low-dose psychedelic therapy style from Europe.</p>
<p><strong>Psychonautics</strong> — Exploration of consciousness through altered states.</p>
<p><strong>Psychotomimetic</strong> — “Psychosis-mimicking”; outdated term for psychedelics.</p>
<p><strong>PTSD</strong> — Post-traumatic stress disorder; treated with MDMA therapy.</p>
<h2 id="q">Q<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#q" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Qualia</strong> — Subjective conscious experiences; altered by psychedelics.</p>
<h2 id="r">R<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#r" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Ralph Metzner</strong> — Psychologist; co-author of “The Psychedelic Experience” with Leary and Alpert. <a href="../02_PEOPLE/The-Cultural-Catalysts/Ram-Dass" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Ram-Dass">Ram Dass</a> <a href="../02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary">Timothy Leary</a></p>
<p><strong><a href="../02_PEOPLE/The-Cultural-Catalysts/Ram-Dass" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Ram-Dass">Ram Dass</a>(Richard Alpert)</strong> — Harvard psychologist turned spiritual teacher after psychedelics.</p>
<p><strong>Randomized controlled trial (RCT)</strong> — Gold standard research design.</p>
<p><strong>Rapid tolerance</strong> — Quick development of reduced effects with repeated use.</p>
<p><strong>REBUS</strong> — “Relaxed Beliefs Under Psychedelics”; Carhart-Harris model.</p>
<p><strong>Receptor</strong> — Protein that binds molecules to trigger cellular response.</p>
<p><strong>Receptor binding profile</strong> — Pattern of receptor affinities determining drug effects.</p>
<p><strong>Research chemicals</strong> — Novel psychoactive substances with limited safety data.</p>
<p><strong>Reverse tolerance</strong> — Increased sensitivity with repeated use; reported with some substances.</p>
<p><strong><a href="../02_PEOPLE/The-Advocates--and--Institution-Builders/Rick-Doblin" class="internal alias" data-slug="02_PEOPLE/The-Advocates--and--Institution-Builders/Rick-Doblin">Rick Doblin</a></strong> — Founder of MAPS; advocate for psychedelic medicine.</p>
<p><strong><a href="../02_PEOPLE/The-Neuroscientists--and--Clinical-Researchers/Rick-Strassman" class="internal alias" data-slug="02_PEOPLE/The-Neuroscientists--and--Clinical-Researchers/Rick-Strassman">Rick Strassman</a></strong> — Psychiatrist who conducted 1990s DMT studies; coined “spirit molecule.” <a href="../04_REFERENCES/Books/DMT---The-Spirit-Molecule" class="internal alias" data-slug="04_REFERENCES/Books/DMT---The-Spirit-Molecule">DMT - The Spirit Molecule</a></p>
<p><strong>Roland Griffiths</strong> — Johns Hopkins researcher establishing modern psilocybin research.</p>
<h2 id="s">S<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#s" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Salvia divinorum</strong> — Plant containing Salvinorin A; unique kappa-opioid dissociative. <a href="../Other-Compounds" class="internal alias" data-slug="Other-Compounds">Other Compounds</a></p>
<p><strong>Salvinorin A</strong> — Most potent natural psychedelic; non-nitrogenous diterpenoid.</p>
<p><strong>San Pedro</strong> — Mescaline-containing cactus (Echinopsis pachanoi).</p>
<p><strong>Santo Daime</strong> — Brazilian ayahuasca religion with legal status. <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a> <a href="../03_CONCEPTS/Ayahuasca-Tourism" class="internal alias" data-slug="03_CONCEPTS/Ayahuasca-Tourism">Ayahuasca Tourism</a></p>
<p><strong>Schedule I</strong> — Most restrictive drug classification; “no medical use, high abuse potential.”</p>
<p><strong>Selective serotonin reuptake inhibitor (SSRI)</strong> — Antidepressant class; blocks psychedelic effects.</p>
<p><strong>Serotonin (5-HT)</strong> — Neurotransmitter; psychedelics are structural analogs.</p>
<p><strong>Serotonin syndrome</strong> — Dangerous serotonin excess; risk with MAOI combinations.</p>
<p><strong>Set and setting</strong> — Mental state and environment shaping psychedelic experience. <a href="../03_CONCEPTS/Set,-Setting-and-the-Substance" class="internal alias" data-slug="03_CONCEPTS/Set,-Setting-and-the-Substance">Set, Setting and the Substance</a></p>
<p><strong>Shulgin, Alexander “Sasha”</strong> — See <a href="../02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin" class="internal alias" data-slug="02_PEOPLE/The-Chemists--and--Pharmacologists/Alexander-Shulgin">Alexander Shulgin</a>.</p>
<p><strong>Shulgin rating scale</strong> — Plus/minus system for recording psychedelic effects. <a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a> <a href="../01_SUBSTANCES/Synthetic-Classes/Phenethylamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Phenethylamines">Phenethylamines</a></p>
<p><strong>Sigma-1 receptor</strong> — Protein potentially involved in DMT effects.</p>
<p><strong>Silent darkness</strong> — <a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna">Terence McKenna</a>’s recommended setting for deep experiences.</p>
<p><strong>Solomon Snyder</strong> — Neuroscientist who discovered opioid receptors.</p>
<p><strong>Spiritual emergency</strong> — Stanislav Grof’s term for challenging transformative experience.</p>
<p><strong>Stephen Szára</strong> — First to inject pure <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a> in humans (1956). <a href="../01_SUBSTANCES/CLASSICS/DMT" class="internal" data-slug="01_SUBSTANCES/CLASSICS/DMT">DMT</a></p>
<p><strong>Synesthesia</strong> — Cross-sensory perception (seeing sounds, hearing colors).</p>
<p><strong>Synthetic</strong> — Laboratory-created rather than naturally occurring.</p>
<h2 id="t">T<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#t" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Tabernanthe iboga</strong> — African shrub containing ibogaine. <a href="../01_SUBSTANCES/Ethnobotanical/Ibogain" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ibogain">Ibogain</a></p>
<p><strong>Tachyphylaxis</strong> — Acute tolerance during single session.</p>
<p><strong><a href="../02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna" class="internal alias" data-slug="02_PEOPLE/The-Ethnobotanists--and--Anthropologists/Terence-McKenna">Terence McKenna</a></strong> — Ethnobotanist popularizing DMT and “heroic doses.”</p>
<p><strong>Therapeutic index</strong> — Ratio of toxic to therapeutic dose; safety measure.</p>
<p><strong>Therapeutic window</strong> — Dose range producing desired effects without toxicity.</p>
<p><strong>Threshold dose</strong> — Minimum amount producing barely perceptible effects.</p>
<p><strong><a href="../01_SUBSTANCES/Synthetic-Classes/Tryptamines" class="internal" data-slug="01_SUBSTANCES/Synthetic-Classes/Tryptamines">Tryptamines</a></strong> — “Tryptamines I Have Known And Loved”; Shulgin’s tryptamine compendium.</p>
<p><strong><a href="../02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary" class="internal alias" data-slug="02_PEOPLE/The-Cultural-Catalysts/Timothy-Leary">Timothy Leary</a></strong> — Harvard psychologist turned countercultural icon.</p>
<p><strong>Tolerance</strong> — Reduced response requiring higher doses for same effect.</p>
<p><strong>Transpersonal psychology</strong> — Field studying experiences beyond individual ego.</p>
<p><strong>Trip</strong> — Colloquial term for psychedelic experience. <a href="../03_CONCEPTS/Perspectives-and-Framing" class="internal alias" data-slug="03_CONCEPTS/Perspectives-and-Framing">Perspectives and Framing</a></p>
<p><strong>Trip killer</strong> — Substance ending psychedelic effects (benzodiazepines, antipsychotics).</p>
<p><strong>Trip report</strong> — Detailed account of psychedelic experience.</p>
<p><strong>Trip sitter</strong> — Sober companion ensuring safety during experience.</p>
<p><strong>Tryptamine</strong> — Core structure of DMT, psilocin, LSD, serotonin.</p>
<p><strong>Tryptophan</strong> — Amino acid precursor to serotonin and DMT.</p>
<h2 id="u">U<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#u" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>UDV (União do Vegetal)</strong> — Brazilian ayahuasca religion.</p>
<p><strong>Underground therapy</strong> — Illegal psychedelic-assisted therapy.</p>
<p><strong>Unity experience</strong> — Feeling of oneness with universe/others.</p>
<h2 id="v">V<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#v" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Vasoconstriction</strong> — Blood vessel narrowing; side effect of ergot derivatives.</p>
<p><strong>Visual acuity enhancement</strong> — Increased visual detail perception.</p>
<p><strong>Visual drifting</strong> — Objects appearing to breathe or flow.</p>
<p><strong>Visionary state</strong> — Immersive visual experience transcending ordinary perception.</p>
<h2 id="w">W<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#w" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>War on Drugs</strong> — Political campaign criminalizing psychedelics since 1970s.</p>
<p><strong>Wasson, R. Gordon</strong> — Publicized psilocybin mushrooms to Western world.</p>
<p><strong>William James</strong> — Philosopher/psychologist who experimented with nitrous oxide.</p>
<h2 id="x">X<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#x" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Xenobiotic</strong> — Foreign substance metabolized by body.</p>
<h2 id="y">Y<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#y" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Yagé</strong> — Alternative name for <a href="../01_SUBSTANCES/Ethnobotanical/Ayahuasca" class="internal" data-slug="01_SUBSTANCES/Ethnobotanical/Ayahuasca">Ayahuasca</a>.</p>
<p><strong>Yopo</strong> — Anadenanthera snuff containing DMT and 5-MeO-DMT.</p>
<h2 id="z">Z<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#z" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Zendo Project</strong> — MAPS harm reduction services at festivals.</p>
<hr/>
<h2 id="additional-key-concepts">Additional Key Concepts<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#additional-key-concepts" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<p><strong>Bioassay</strong> — Testing substance effects on living organism; Shulgin’s self-experimentation method.</p>
<p><strong>Consensual reality</strong> — Shared ordinary perception; contrasted with psychedelic states.</p>
<p><strong>Death and rebirth</strong> — Archetypal experience of ego dissolution and reconstitution.</p>
<p><strong>Ineffability</strong> — Inability to adequately describe mystical/psychedelic experiences in words.</p>
<p><strong>Jungian archetypes</strong> — Universal symbols emerging in psychedelic visions.</p>
<p><strong>Kundalini</strong> — Energy/consciousness described in yoga; sometimes activated by psychedelics.</p>
<p><strong>Liminal space</strong> — Threshold between ordinary and non-ordinary consciousness.</p>
<p><strong>Noetic quality</strong> — Sense of encountering profound truth during mystical experience.</p>
<p><strong>Ontological shock</strong> — Radical questioning of reality’s nature after psychedelic experience.</p>
<p><strong>Paradoxical healing</strong> — Recovery through fully experiencing difficult emotions.</p>
<p><strong>Radical acceptance</strong> — Complete openness to experience; key to navigating difficult trips.</p>
<p><strong>Sacred geometry</strong> — Mathematical patterns in psychedelic visions.</p>
<p><strong>Transcendent other</strong> — Encounter with seemingly external intelligence.</p>
<p><strong>White light experience</strong> — Encounter with brilliant luminosity in mystical states.</p>
<p><strong>Xenolinguistics</strong> — Study of non-human languages; relevant to DMT entity communication.</p></article><hr/><div class="page-footer"></div></div><div class="right sidebar"><div class="graph"><h3>Graph View</h3><div class="graph-outer"><div class="graph-container" data-cfg="{&quot;drag&quot;:true,&quot;zoom&quot;:true,&quot;depth&quot;:1,&quot;scale&quot;:1.1,&quot;repelForce&quot;:0.5,&quot;centerForce&quot;:0.3,&quot;linkDistance&quot;:30,&quot;fontSize&quot;:0.6,&quot;opacityScale&quot;:1,&quot;showTags&quot;:true,&quot;removeTags&quot;:[],&quot;focusOnHover&quot;:false,&quot;enableRadial&quot;:false}"></div><button class="global-graph-icon" aria-label="Global Graph"><svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 55 55" fill="currentColor" xml:space="preserve"><path d="M49,0c-3.309,0-6,2.691-6,6c0,1.035,0.263,2.009,0.726,2.86l-9.829,9.829C32.542,17.634,30.846,17,29,17
                s-3.542,0.634-4.898,1.688l-7.669-7.669C16.785,10.424,17,9.74,17,9c0-2.206-1.794-4-4-4S9,6.794,9,9s1.794,4,4,4
                c0.74,0,1.424-0.215,2.019-0.567l7.669,7.669C21.634,21.458,21,23.154,21,25s0.634,3.542,1.688,4.897L10.024,42.562
                C8.958,41.595,7.549,41,6,41c-3.309,0-6,2.691-6,6s2.691,6,6,6s6-2.691,6-6c0-1.035-0.263-2.009-0.726-2.86l12.829-12.829
                c1.106,0.86,2.44,1.436,3.898,1.619v10.16c-2.833,0.478-5,2.942-5,5.91c0,3.309,2.691,6,6,6s6-2.691,6-6c0-2.967-2.167-5.431-5-5.91
                v-10.16c1.458-0.183,2.792-0.759,3.898-1.619l7.669,7.669C41.215,39.576,41,40.26,41,41c0,2.206,1.794,4,4,4s4-1.794,4-4
                s-1.794-4-4-4c-0.74,0-1.424,0.215-2.019,0.567l-7.669-7.669C36.366,28.542,37,26.846,37,25s-0.634-3.542-1.688-4.897l9.665-9.665
                C46.042,11.405,47.451,12,49,12c3.309,0,6-2.691,6-6S52.309,0,49,0z M11,9c0-1.103,0.897-2,2-2s2,0.897,2,2s-0.897,2-2,2
                S11,10.103,11,9z M6,51c-2.206,0-4-1.794-4-4s1.794-4,4-4s4,1.794,4,4S8.206,51,6,51z M33,49c0,2.206-1.794,4-4,4s-4-1.794-4-4
                s1.794-4,4-4S33,46.794,33,49z M29,31c-3.309,0-6-2.691-6-6s2.691-6,6-6s6,2.691,6,6S32.309,31,29,31z M47,41c0,1.103-0.897,2-2,2
                s-2-0.897-2-2s0.897-2,2-2S47,39.897,47,41z M49,10c-2.206,0-4-1.794-4-4s1.794-4,4-4s4,1.794,4,4S51.206,10,49,10z"></path></svg></button></div><div class="global-graph-outer"><div class="global-graph-container" data-cfg="{&quot;drag&quot;:true,&quot;zoom&quot;:true,&quot;depth&quot;:-1,&quot;scale&quot;:0.9,&quot;repelForce&quot;:0.5,&quot;centerForce&quot;:0.2,&quot;linkDistance&quot;:30,&quot;fontSize&quot;:0.6,&quot;opacityScale&quot;:1,&quot;showTags&quot;:true,&quot;removeTags&quot;:[],&quot;focusOnHover&quot;:true,&quot;enableRadial&quot;:true}"></div></div></div><div class="toc desktop-only"><button type="button" class="toc-header" aria-controls="toc-content" aria-expanded="true"><h3>Table of Contents</h3><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="fold"><polyline points="6 9 12 15 18 9"></polyline></svg></button><div class="toc-content"><ul id="16uzmh" class="overflow"><li class="depth-0"><a href="#a" data-for="a">A</a></li><li class="depth-0"><a href="#b" data-for="b">B</a></li><li class="depth-0"><a href="#c" data-for="c">C</a></li><li class="depth-0"><a href="#d" data-for="d">D</a></li><li class="depth-0"><a href="#e" data-for="e">E</a></li><li class="depth-0"><a href="#f" data-for="f">F</a></li><li class="depth-0"><a href="#g" data-for="g">G</a></li><li class="depth-0"><a href="#h" data-for="h">H</a></li><li class="depth-0"><a href="#i" data-for="i">I</a></li><li class="depth-0"><a href="#j" data-for="j">J</a></li><li class="depth-0"><a href="#k" data-for="k">K</a></li><li class="depth-0"><a href="#l" data-for="l">L</a></li><li class="depth-0"><a href="#m" data-for="m">M</a></li><li class="depth-0"><a href="#n" data-for="n">N</a></li><li class="depth-0"><a href="#o" data-for="o">O</a></li><li class="depth-0"><a href="#p" data-for="p">P</a></li><li class="depth-0"><a href="#q" data-for="q">Q</a></li><li class="depth-0"><a href="#r" data-for="r">R</a></li><li class="depth-0"><a href="#s" data-for="s">S</a></li><li class="depth-0"><a href="#t" data-for="t">T</a></li><li class="depth-0"><a href="#u" data-for="u">U</a></li><li class="depth-0"><a href="#v" data-for="v">V</a></li><li class="depth-0"><a href="#w" data-for="w">W</a></li><li class="depth-0"><a href="#x" data-for="x">X</a></li><li class="depth-0"><a href="#y" data-for="y">Y</a></li><li class="depth-0"><a href="#z" data-for="z">Z</a></li><li class="depth-0"><a href="#additional-key-concepts" data-for="additional-key-concepts">Additional Key Concepts</a></li><li class="overflow-end"></li></ul></div></div></div><footer class><p>Created with <a href="https://quartz.jzhao.xyz/">Quartz v4.5.0</a> © 2026</p><ul></ul></footer></div></div></body><script type="application/javascript">function o(){let t=this.parentElement;t.classList.toggle("is-collapsed");let e=t.classList.contains("is-collapsed")?this.scrollHeight:t.scrollHeight;t.style.maxHeight=e+"px";let c=t,l=t.parentElement;for(;l;){if(!l.classList.contains("callout"))return;let i=l.classList.contains("is-collapsed")?l.scrollHeight:l.scrollHeight+c.scrollHeight;l.style.maxHeight=i+"px",c=l,l=l.parentElement}}function n(){let t=document.getElementsByClassName("callout is-collapsible");for(let s of t){let e=s.firstElementChild;if(!e)continue;e.addEventListener("click",o),window.addCleanup(()=>e.removeEventListener("click",o));let l=s.classList.contains("is-collapsed")?e.scrollHeight:s.scrollHeight;s.style.maxHeight=l+"px"}}document.addEventListener("nav",n);
</script><script type="module">function f(i,e){if(!i)return;function r(o){o.target===this&&(o.preventDefault(),o.stopPropagation(),e())}function t(o){o.key.startsWith("Esc")&&(o.preventDefault(),e())}i?.addEventListener("click",r),window.addCleanup(()=>i?.removeEventListener("click",r)),document.addEventListener("keydown",t),window.addCleanup(()=>document.removeEventListener("keydown",t))}function y(i){for(;i.firstChild;)i.removeChild(i.firstChild)}var h=class{constructor(e,r){this.container=e;this.content=r;this.setupEventListeners(),this.setupNavigationControls(),this.resetTransform()}isDragging=!1;startPan={x:0,y:0};currentPan={x:0,y:0};scale=1;MIN_SCALE=.5;MAX_SCALE=3;cleanups=[];setupEventListeners(){let e=this.onMouseDown.bind(this),r=this.onMouseMove.bind(this),t=this.onMouseUp.bind(this),o=this.resetTransform.bind(this);this.container.addEventListener("mousedown",e),document.addEventListener("mousemove",r),document.addEventListener("mouseup",t),window.addEventListener("resize",o),this.cleanups.push(()=>this.container.removeEventListener("mousedown",e),()=>document.removeEventListener("mousemove",r),()=>document.removeEventListener("mouseup",t),()=>window.removeEventListener("resize",o))}cleanup(){for(let e of this.cleanups)e()}setupNavigationControls(){let e=document.createElement("div");e.className="mermaid-controls";let r=this.createButton("+",()=>this.zoom(.1)),t=this.createButton("-",()=>this.zoom(-.1)),o=this.createButton("Reset",()=>this.resetTransform());e.appendChild(t),e.appendChild(o),e.appendChild(r),this.container.appendChild(e)}createButton(e,r){let t=document.createElement("button");return t.textContent=e,t.className="mermaid-control-button",t.addEventListener("click",r),window.addCleanup(()=>t.removeEventListener("click",r)),t}onMouseDown(e){e.button===0&&(this.isDragging=!0,this.startPan={x:e.clientX-this.currentPan.x,y:e.clientY-this.currentPan.y},this.container.style.cursor="grabbing")}onMouseMove(e){this.isDragging&&(e.preventDefault(),this.currentPan={x:e.clientX-this.startPan.x,y:e.clientY-this.startPan.y},this.updateTransform())}onMouseUp(){this.isDragging=!1,this.container.style.cursor="grab"}zoom(e){let r=Math.min(Math.max(this.scale+e,this.MIN_SCALE),this.MAX_SCALE),t=this.content.getBoundingClientRect(),o=t.width/2,n=t.height/2,c=r-this.scale;this.currentPan.x-=o*c,this.currentPan.y-=n*c,this.scale=r,this.updateTransform()}updateTransform(){this.content.style.transform=`translate(${this.currentPan.x}px, ${this.currentPan.y}px) scale(${this.scale})`}resetTransform(){this.scale=1;let e=this.content.querySelector("svg");this.currentPan={x:e.getBoundingClientRect().width/2,y:e.getBoundingClientRect().height/2},this.updateTransform()}},C=["--secondary","--tertiary","--gray","--light","--lightgray","--highlight","--dark","--darkgray","--codeFont"],E;document.addEventListener("nav",async()=>{let e=document.querySelector(".center").querySelectorAll("code.mermaid");if(e.length===0)return;E||=await import("https://cdnjs.cloudflare.com/ajax/libs/mermaid/11.4.0/mermaid.esm.min.mjs");let r=E.default,t=new WeakMap;for(let n of e)t.set(n,n.innerText);async function o(){for(let s of e){s.removeAttribute("data-processed");let a=t.get(s);a&&(s.innerHTML=a)}let n=C.reduce((s,a)=>(s[a]=window.getComputedStyle(document.documentElement).getPropertyValue(a),s),{}),c=document.documentElement.getAttribute("saved-theme")==="dark";r.initialize({startOnLoad:!1,securityLevel:"loose",theme:c?"dark":"base",themeVariables:{fontFamily:n["--codeFont"],primaryColor:n["--light"],primaryTextColor:n["--darkgray"],primaryBorderColor:n["--tertiary"],lineColor:n["--darkgray"],secondaryColor:n["--secondary"],tertiaryColor:n["--tertiary"],clusterBkg:n["--light"],edgeLabelBackground:n["--highlight"]}}),await r.run({nodes:e})}await o(),document.addEventListener("themechange",o),window.addCleanup(()=>document.removeEventListener("themechange",o));for(let n=0;n<e.length;n++){let v=function(){let g=l.querySelector("#mermaid-space"),m=l.querySelector(".mermaid-content");if(!m)return;y(m);let w=c.querySelector("svg").cloneNode(!0);m.appendChild(w),l.classList.add("active"),g.style.cursor="grab",u=new h(g,m)},M=function(){l.classList.remove("active"),u?.cleanup(),u=null},c=e[n],s=c.parentElement,a=s.querySelector(".clipboard-button"),d=s.querySelector(".expand-button"),p=window.getComputedStyle(a),L=a.offsetWidth+parseFloat(p.marginLeft||"0")+parseFloat(p.marginRight||"0");d.style.right=`calc(${L}px + 0.3rem)`,s.prepend(d);let l=s.querySelector("#mermaid-container");if(!l)return;let u=null;d.addEventListener("click",v),f(l,M),window.addCleanup(()=>{u?.cleanup(),d.removeEventListener("click",v)})}});
</script><script src="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/contrib/copy-tex.min.js" type="application/javascript"></script><script src="../postscript.js" type="module"></script></html>